2016, Feb;38(2):98102
Andreeff M , R-Y W, Davis E, Jacamo R, Ruvolo P, McQueen T, Huang X, Battula VL, Chen Y, Majumdar S, Benito JM, Zeng Z, Benton C, Carter B, Mu H, Ma W, Ruvolo V, Hodgson L, Konoplev S, Pan R, Somanchi A, Strunck D, Zhang Q, Kornblau SM, Kantarjian H, Marcucci G, Garzon R, Zuber J, Lowe S, Croce C, Konopleva M
Symptoms and Clinical Presentations Patients with carnitine biosynthesis disorders may exhibit symptoms such as muscle weakness, hypoglycemia, cardiomyopathy, and liver dysfunction
These FGIDs have recently been renamed to disorders of the gut-brain axis (DGBIs)
Most are mild and improve over time, while serious side effects are rare but important to recognize